Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
31%
ALSO IN XPH
XPH
55
HOLDINGS
31%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
VIATRIS, INC. | 3.8% | 2.1% | 2.1% |
|
MERCK & CO. INC. | 7.7% | 2.1% | 2.1% |
|
ELI LILLY & CO | 4.4% | 2.0% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% | 2.0% | 2.0% |
|
JOHNSON & JOHNSON | 7.5% | 2.0% | 2.0% |
FTXH Overweight Relative to XPH
|
ABBVIE INC | 6.3% |
|
MERCK & CO. INC. | 5.7% |
|
JOHNSON & JOHNSON | 5.5% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% |
|
PFIZER INC | 4.4% |
|
CARDINAL HEALTH INC | 4.2% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
BIOGEN IDEC INC | 3.8% |
|
GILEAD SCIENCES INC | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
FTXH Underweight Relative to XPH
|
ORGANON & CO. | -2.5% |
|
AXSOME THERAPEUTICS, INC. | -2.3% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.3% |
|
EDGEWISE THERAPEUTICS, INC. | -2.2% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.2% |
|
CRINETICS PHARMACEUTICALS INC | -2.1% |
|
ROYALTY PHARMA PLC CLASS A | -2.0% |
|
BIOSANTE PHARMACEUTICALS INC | -1.9% |
|
ARVINAS, INC. | -1.8% |
|
ENLIVEN THERAPEUTICS, INC. | -1.8% |